Bon Secours Mercy Health and Lirio will collaborate to develop personalized programs based on clinical data to improve health-related decision-making for patients at risk for chronic diseases including diabetes and hypertension, Justin McGoldrick, MD, the health system’s chief clinical research and innovation officer, explained in the announcement.
The partners will ultimately commercialize the resulting programs for use by other health systems, and Bon Secours Mercy Health will also implement Lirio’s existing programs for use across the health system.
More articles on AI:
Top 10 AI applications for healthcare in 2020: Accenture report
Physicians see 25% of their work being automated in the future, survey finds
Crouse Health deploys AI-enabled stroke detection
